Additional Supporting Information may be found in the online version of this article.

MDS_25042_sm_SuppInfo.doc41KSupporting Information
MDS_25042_sm_SuppTab1.doc40KSupporting Information e-Table 1: Clinical data of PD patients showing disease duration and motor disability (UPDRS III) and their treatment. The daily L-dopa equivalent unit (LEU) dose for each patient is given (Evans et al. 2004).
MDS_25042_sm_SuppTab2.doc89KSupporting Information e-Table 2: Eye movement parameters during trapezoid ramp stimulation in the four different paradigms (conditions): A=pure ramp, B=early onset blanking, C=mid-ramp blanking, D=short ramp blanking. Significant differences between PD patients and controls are labelled bold.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.